Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

por Tefferi, A, Saeed, L, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N
Publicado 2017

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

por Barraco, D, Cerquozzi, S, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N, Tefferi, A
Publicado 2017

Liver function test abnormalities and their clinical relevance in primary myelofibrosis

por Barraco, D, Mudireddy, M, Shah, S, Hanson, C A, Ketterling, R P, Gangat, N, Pardanani, A, Tefferi, A
Publicado 2017

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

por Cerquozzi, S., Barraco, D., Lasho, T., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A., Gangat, N., Tefferi, A.
Publicado 2017

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

por Patnaik, M M, Lasho, T L, Vijayvargiya, P, Finke, C M, Hanson, C A, Ketterling, R P, Gangat, N, Tefferi, A
Publicado 2016

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia

por Lasho, T L, Finke, C M, Zblewski, D, Patnaik, M, Ketterling, R P, Chen, D, Hanson, C A, Tefferi, A, Pardanani, A
Publicado 2015

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

por Greenberg, A J, Philip, S, Paner, A, Velinova, S, Badros, A, Catchatourian, R, Ketterling, R, Kyle, R A, Kumar, S, Vachon, C M, Rajkumar, S V
Publicado 2015

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

por Greenberg, A J, Philip, S, Paner, A, Velinova, S, Badros, A, Catchatourian, R, Ketterling, R, Kyle, R A, Kumar, S, Vachon, C M, Rajkumar, S V
Publicado 2015

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

por Patnaik, M M, Zahid, M F, Lasho, T L, Finke, C, Ketterling, R L, Gangat, N, Robertson, K D, Hanson, C A, Tefferi, A
Publicado 2016

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

por Laborde, R R, Patnaik, M M, Lasho, T L, Finke, C M, Hanson, C A, Knudson, R A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado 2013

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

por Barraco, D, Elala, Y C, Lasho, T L, Begna, K H, Gangat, N, Finke, C, Hanson, C A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado 2016

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

por Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A
Publicado 2016

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

por Barraco, D, Elala, Y C, Lasho, T L, Begna, K H, Gangat, N, Finke, C, Hanson, C A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado 2016

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis

por Patnaik, M M, Timm, M M, Vallapureddy, R, Lasho, T L, Ketterling, R P, Gangat, N, Shi, M, Tefferi, A, Solary, E, Reichard, K K, Jevremovic, D
Publicado 2017

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

por Pardanani, A, Abdelrahman, R A, Finke, C, Lasho, T T, Begna, K H, Al-Kali, A, Hogan, W J, Litzow, M R, Hanson, C A, Ketterling, R P, Tefferi, A
Publicado 2015

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

por Saeed, L, Patnaik, M M, Begna, K H, Al-Kali, A, Litzow, M R, Hanson, C A, Ketterling, R P, Porrata, L F, Pardanani, A, Gangat, N, Tefferi, A
Publicado 2017

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado 2015

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

por Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E
Publicado 2015

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations...

por Patnaik, M M, Lasho, T L, Finke, C M, Gangat, N, Caramazza, D, Holtan, S G, Pardanani, A, Knudson, R A, Ketterling, R P, Chen, D, Hoyer, J D, Hanson, C A, Tefferi, A
Publicado 2010

Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course

por Chavan, R N, Bridges, A G, Knudson, R A, Ketterling, R P, Comfere, N, Wada, D A, Torres-Cabala, C, DiCaudo, D J, Vasmatzis, G, Pittelkow, M R, Feldman, A L
Publicado 2014